Capacity Bio

Capacity’s pipeline includes opportunities in neurodegenerative and autoimmune disorders, myopathies, and genetic orphan indications. Capacity Bio’s proprietary approach is to develop small molecules, peptides, and nanoparticles that enhance identification of dysfunctional mitochondria, activate mitophagy pathways, and promote clearance by autophagosomes and lysosomes. From company website Source · Oct 13, 2026

Keywords: small molecules peptides activate mitophagy